Clinical Trials
368
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (323 trials with phase data)• Click on a phase to view related trials
Randomized Pilot Trial of AYUDA Program for Younger Latinx Adults With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Kaiser Permanente
- Target Recruit Count
- 204
- Registration Number
- NCT07019649
- Locations
- 🇺🇸
Kaiser Permanente Northern California, Pleasanton, California, United States
Addressing Social Needs to Improve Health in Adults With Multiple Chronic Conditions
- Conditions
- Multiple Chronic Conditions
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Kaiser Permanente
- Target Recruit Count
- 800
- Registration Number
- NCT06941519
- Locations
- 🇺🇸
Division of Research, Pleasanton, California, United States
Randomized Trial of HIFU vs. Cryo for Prostate Cancer
- Conditions
- Prostate Cancer Stage ICryoablationProstate CancerHigh Intensity Focused UltrasoundProstate Cancer Stage IIHIFU
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Kaiser Permanente
- Target Recruit Count
- 50
- Registration Number
- NCT06929065
- Locations
- 🇺🇸
Kaiser Permanente, Los Angeles, California, United States
Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
- Conditions
- Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 Diabetes (T2D)
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Kaiser Permanente
- Target Recruit Count
- 204
- Registration Number
- NCT06906653
- Locations
- 🇺🇸
Kaiser Permanente Division of Research, Pleasanton, California, United States
Grasshopper: a Novel Clinical Dashboard for Radiologists
- Conditions
- Chest InfectionPulmonary Edema - Acute
- First Posted Date
- 2025-01-21
- Last Posted Date
- 2025-01-21
- Lead Sponsor
- Kaiser Permanente
- Target Recruit Count
- 100000
- Registration Number
- NCT06785246
- Locations
- 🇺🇸
Kaiser Permanente Northern California Division of Research, Pleasanton, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 74
- Next
News
Abridge Secures $300M Series E Funding, Reaches $5.3B Valuation for AI Clinical Documentation Platform
Abridge raised $300 million in Series E funding led by Andreessen Horowitz, bringing its valuation to $5.3 billion for its ambient listening technology that automates clinical documentation.
Kaiser Permanente Launches FDA-Approved Gene Therapy Program for Pediatric Sickle Cell Disease
Kaiser Permanente Southern California will launch an FDA-approved gene therapy program for pediatric sickle cell disease patients through a partnership with Downey Medical Center and City of Hope.
Autism Diagnoses Surge 175% in the U.S. Over Past Decade, Study Reveals
New research from Kaiser Permanente shows autism diagnoses increased by 175% between 2011 and 2022, with the latest CDC data indicating 1 in 31 U.S. children are now affected.
Wildfire Smoke Exposure Linked to Prolonged Cardiovascular and Respiratory Health Risks
New research reveals that wildfire smoke exposure increases hospitalization risk for heart and lung conditions for up to three months after the smoke clears.
Healthcare LLMs Face Critical Equity Challenges: New Guidelines Address Bias and Access Concerns
Large Language Models in healthcare show promise but face significant challenges in addressing linguistic bias, accessibility, and quality control across diverse patient populations.
NIH Study Evaluates Text Messaging Strategies to Improve Cardiovascular Care Management
Chat 4 Heart Health trial investigates three distinct text messaging approaches to enhance patient self-management behaviors in cardiovascular care.
Evolution of Managed Care: Three Decades of Healthcare Transformation and Future Outlook
• Managed care has evolved significantly over 30 years, bringing advances in prevention, guidelines implementation, and quality metrics, with vaccination rates rising from 50% to over 90% before the COVID-19 era. • Healthcare payment models have cycled through various iterations, from traditional capitation to modern value-based contracting, with data analytics and AI emerging as key drivers of system efficiency. • Corporate consolidation in healthcare has entered its third wave, with 75% of providers now employed by larger organizations, presenting both opportunities and challenges for patient care delivery.
DoxyPEP Demonstrates Significant Reduction in STIs in Real-World Setting
A recent study published in JAMA Internal Medicine reveals that doxycycline post-exposure prophylaxis (doxyPEP) is associated with substantial declines in bacterial STIs.
Kaiser Permanente Pharmacist Outlines Key Challenges in Value-Based Care Implementation
Kaiser Permanente's Tim Mok emphasizes the critical balance between patient outcomes, provider experience, and safety management in pharmacy decision-making processes.
Email Reminders Boost Flu Shot Rates, Especially Among Heart Attack Survivors
Electronic reminders highlighting cardiovascular benefits significantly improved flu vaccination rates in Denmark.